Health Catalyst, Inc.

For the period ended Mar 31, 2026. Filed May 11, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 11, 2026

HCAT$1.44-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations for the and (unaudited)

Condensed Consolidated Statements of Operations

(in thousands, except per share data)

	Three Months EndedMarch 31,
	2026	2025
Revenue(1):
Technology	$49,468	$51,482
Professional services	21,288	27,931
Total revenue	70,756	79,413
Cost of revenue, excluding depreciation and amortization:
Technology	17,283	17,565
Professional services	18,010	25,613
Total cost of revenue, excluding depreciation and amortization	35,293	43,178
Operating expenses:
Sales and marketing	10,585	14,738
Research and development	9,779	15,186
General and administrative	13,960	14,162
Depreciation and amortization	12,115	12,320
Impairment of goodwill	95,501	—
Total operating expenses	141,940	56,406
Loss from operations	(106,477)	(20,171)
Interest and other expense, net	(4,135)	(3,356)
Loss before income taxes	(110,612)	(23,527)
Income tax provision	(414)	(215)
Net loss	$(111,026)	$(23,742)
Net loss per share, basic and diluted	$(1.53)	$(0.35)
Weighted-average shares outstanding used in calculating net loss per share, basic and diluted	72,593	68,552

(1)Includes amounts attributable to related party transactions. See Note 17 for further details.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.